Effects of Probucol on plasma amyloid-β transport in patients with hyperlipidemia: a 12-week randomized, double-blind, placebo-controlled trial.

The change in plasma Aβ 42 levels from baseline to 12 weeks was also more pronounced in the Probucol group, although the difference did not reach statistical significance (11.44 ± 17.48 vs. 5.35 ± 14.89 pg/ml, P = 0.063).

also in 111,027 other papers